Atorvastatin Calcium Tablet
Product Images NDC 50090-5634

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-5634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)
Chemical structure of Atorvastatin Calcium with a 3-water molecule hydrate. The diagram shows the detailed molecular arrangement of the compound, including aromatic rings, hydroxyl groups, and calcium ion complexation.*
FDA Label Image

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)
A line graph comparing the cumulative incidence percentage over time in years for Atorvastatin versus placebo. The x-axis represents years from 0 to about 3.5, and the y-axis shows cumulative incidence percentage from 0 to 4. The graph includes two lines: a solid line for Atorvastatin, showing consistently lower cumulative incidence than the dashed placebo line. The graph features a hazard ratio (HR) of 0.64 with confidence intervals and a p-value of 0.0005, indicating statistical significance.*
FDA Label Image

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)
A line graph comparing the cumulative hazard percentage over time for Placebo and Atorvastatin groups during a 4-year follow-up. The x-axis represents time to first primary endpoint in years, and the y-axis represents cumulative hazard percentage. The Atorvastatin line shows a lower hazard compared to Placebo, with a hazard ratio (HR) of 0.63 (0.48-0.83) and a p-value of 0.001.*
FDA Label Image

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)
A line graph showing the percentage of subjects experiencing a major cardiovascular event over time, comparing Atorvastatin 10 mg and Atorvastatin 80 mg doses. The x-axis represents time in years up to 5 years, and the y-axis shows percentage of subjects affected. The graph includes a hazard ratio (HR) and p-value indicating statistical analysis.*
FDA Label Image

Label Image (Lbl500905634)

Label Image (Lbl500905634)
The label for Atorvastatin Calcium 20 mg tablets by A-S Medication Solutions. It specifies the oral film-coated tablets containing atorvastatin calcium equivalent to 20 mg atorvastatin. The package contains 30 tablets, with storage instructions at 77 degrees Fahrenheit. Label includes product and lot numbers, a barcode, and packaging location in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.